Bio4Dreams
VC Fund
Bresso, Italy
Bio4Dreams is an entirely privately certified incubator born in 2017 fully dedicated to very early stage innovative startups in Life Sciences, who helps exceptional people to exploit the results of their scientific research, working alongside all the subjects of the innovation chain to create sustainable, pragmatic, and long-lasting business pathswith an international scope.Our peculiarity is the ability to think out of the box. We aim to create a broad international innovation ecosystem in Life Sciences, with Bio4Dreams standing as a reference point and beacon for entrepreneurial ideas.We go well beyond the traditional definition of startup incubator because we follow the entire development path of a single project, starting from its very early stages.Furthermore, we do not limit ourselves to an ordinary interaction with the main innovation players, but we work to integrate them into a wider ecosystem.Key strengths of Bio4Dreams are its fully customized and flexible incubation programs, built through common and validated methodologies, coupled with its international vocation, which gives startups a real chance to immediately start competing on a global scale.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Bio4Dreams invests in
Stages Bio4Dreams invests in
Countries Bio4Dreams invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Costanza Conti
|
|||
Demetra Pelos
|
|||
Fabio Bianco
|
|||
Laura Fagnani
|
Investment Focus
Industry
- Health Care 3 (33%)
- Life Science 3 (33%)
- Biotechnology 3 (33%)
- Medical Device 2 (22%)
- Medical 1 (11%)
Stage
- Seed 7 (78%)
- Series B 1 (11%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Costanza Conti
Head of Grant Office
|
Head of Grant Office | Total investments: 0 | Find email | |
|
Demetra Pelos
Head of Business Nursery
|
Head of Business Nursery | Total investments: 0 | Find email | |
Elisabetta Borello
Co-founder, VP Strategy and External Relations
|
Co-founder, VP Strategy and External Relations | Total investments: 2 | Find email | |
|
Fabio Bianco
CSO
|
CSO | Total investments: 0 | Find email | |
|
Laura Fagnani
Business Administration Responsible
|
Business Administration Responsible | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
ChemiCare
|
A Start Up founded in December 2016 and committed to the discovery and development of orphan drugs for patients affected by calcium-related genetic diseases. ChemICare’s mission is the improvement of the quality of life of patients affected by Tubular Aggregate Myopathy, York Platelet Syndrome and Stormorken Syndrome by the development of a therapythat restores the abnormal intracellular calcium level, a common feature of these three rare diseases. | $2.9M / Seed / Dec 18, 2025 | |
Simplifica
|
Simplifica develops modular digital platforms supported by mathematical models to accelerate predictive analyses on healthcare data. | $13.6K / Seed / Jun 01, 2025 | |
BEEP Factory
|
Beep Factory provides support in prototyping devices and instruments in the Life Sciences and bioengineering fields. | $26.8K / Seed / May 01, 2024 | |
Evotion
|
Evotion is a health monitoring smart wearable company. | $161.2K / Seed / Dec 01, 2023 | |
Euleria Health
|
Euleria is a provider of digital rehabilitation devices and solutions for better recovery of patients. | $1.5M / Seed / Mar 14, 2022 | |
NanoPhoenix
|
NanoPhoenix is providing nanotechnologies for life sciences. The company develops micro and nanostructured devices and surfaces for cell biology studies, biosensors, and labs-on-chips in the diagnostic and therapeutic fields. They provide design, manufacturing, testing, prototyping, and production. | $39.5K / Seed / Feb 01, 2022 | |
|
ChemiCare
|
A Start Up founded in December 2016 and committed to the discovery and development of orphan drugs for patients affected by calcium-related genetic diseases. ChemICare’s mission is the improvement of the quality of life of patients affected by Tubular Aggregate Myopathy, York Platelet Syndrome and Stormorken Syndrome by the development of a therapythat restores the abnormal intracellular calcium level, a common feature of these three rare diseases. | $248K / Seed / Aug 01, 2021 | |
Labs2Life
|
Labs2Life design and manage research laboratories, including shared ones, relieving researchers of the technical, logistical, and organizational aspects. If you want would contact them please contact them via email. | $14.3K / Seed / Sep 01, 2020 | |
BrainDTech
|
early diagnosis and monitoring of neurological and neurodegenerative diseases in liquid biopsies, based on miRNA from microglial microvesicles. | $226.8K / Series B / Jul 02, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Bio4Dreams invest in?
Bio4Dreams invests primarily in Health Care, Life Science and Biotechnology startups, most often at Seed and Series B stage. Most of the 9 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Bio4Dreams?
Public channels for Bio4Dreams include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Bio4Dreams?
The team at Bio4Dreams includes Costanza Conti (Head of Grant Office), Demetra Pelos (Head of Business Nursery) and Elisabetta Borello (Co-founder, VP Strategy and External Relations), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
